Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly prescribed for the treatment of acute and chronic inflammation, pain, and fever. Most of NSAIDs that are available in market are known to inhibit isoforms, a constitutive form, COX-1 and an inducible form, COX-2 to offer therapeutic effect. However long-term clinical usage of NSAIDs are associated with significant side effects of gastrointestinal lesions, bleeding, and nephrotoxicity. Therefore the discovery of new safer anti-inflammatory drugs represents a challenging goal for such a research area.1-4) On our going medicinal chemistry research program we found that quinazolines and condensed quinazolines exhibit potent central nervous system (CNS) activities like analgesic, antiinflammatory 5) and anticonvulsant. 6) Quinazolin-4(3H)-ones with 2,3-disubstitution is reported to possess significant analgesic, anti-inflammatory 7,8) and anticonvulsant activities.
9)Earlier we have documented 2-phenyl-3-substituted quinazolines, 10) 2-methyl-3-substituted quinazolines, 11) 2-methylthio-3-substituted quinazolines, 12) 2,3-disubstituted quinazolines 13) they exhibited good analgesic and anti-inflammatory activities. The present work is an extension of our ongoing efforts towards the development and identification of new molecules for analgesic and anti-inflammatory activities with minimal gastrointestinal ulceration side effects. With this background in the present study we have synthesized a series of 3-(4-methoxyphenyl)-2-substitutedamino-quinazolin-4(3H)-one. The synthesized compounds were tested for their analgesic, anti-inflammatory and ulcerogenic index activities.
ChemistryThe key intermediate 3-(4-methoxyphenyl)-2-thioxo-2,3-dihydro-quinazolin-4(1H)-one 4 was obtained by reacting 4-methoxyaniline (1) with carbon disulphide and sodium hydroxide in dimethyl sulphoxide to give sodium dithiocarbamate, which was methylated with dimethyl sulphate to afford the dithiocarbamic acid methyl ester (2). Compound 2 on reflux with methyl anthranilate (3) in ethanol yielded the desired 3-(4-methoxyphenyl)-2-thioxo-2,3-dihydro-quinazolin-4(1H)-one (4) via the thiourea intermediate in good yield (80%). The product obtained was cyclic and not an open chain thiourea 3a. It was confirmed by its low Rf value, high melting point and its solubility in sodium hydroxide solution. The IR spectrum of 4 show intense peaks at 3218 cm ÏȘ1 for cyclic thio urea (NH), 1680 cm ÏȘ1 for carbonyl (CÏO) and 1200 cm ÏȘ1 for thioxo (CÏS) stretching. 1 H-NMR spectra of 4 showed singlet at d 3.88 ppm due to OCH 3 group, a multiplet at d 7-8.1 ppm for aromatic (8H) protons and a singlet at d 10.36 ppm indicating the presence of NH. Data from the elemental analyses have been found to be in conformity with the assigned structure. Further the molecular ion recorded in the mass spectrum is also in agreement with the molecular weight of the compound.The 2-methysulfanyl-3-(4-methoxyphenyl)-quinazolin-4(3H)-one 5 was obtained by dissolving 4 in 2% alcoholic sodium hydroxide solution and methylating with ...